Ind-Swift Laboratories: Promoter Group Acquires 14 Lakh Equity Shares

Essix Biosciences Limited, along with other Persons Acting in Concert (PACs) from the Promoter and Promoter Group of Ind-Swift Laboratories Limited, has acquired 14,00,000 (14 Lakh) Equity Shares. This acquisition occurred on October 08, 2026, through the conversion of Fully Convertible Warrants. Following this transaction, the promoter group's holding in Ind-Swift Laboratories has changed. The total number of shares acquired is 14,00,000, representing 1.58% of the total diluted share capital. The total holding of Essix Biosciences Limited and PACs before the acquisition was 3,73,34,278 shares (42.93% of total capital), and after the acquisition, it stands at 3,87,34,278 shares (43.84% of total diluted capital).